Differences in adherence to common inhaled medications in COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 6, 2015, Pages 643-648

  Huurne, Kirsten Koehorst Ter ^a   Movig, Kris ^a   Van Der Valk, Paul ^a   Van Der Palen, Job ^a,b   Brusse Keizer, Marjolein ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

adherence; COPD; inhalation medication; lung function

Indexed keywords

BECLOMETASONE; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CICLESONIDE; FLUTICASONE; SALMETEROL; TIOTROPIUM BROMIDE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; GLUCOCORTICOID;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHARMACY; PRIORITY JOURNAL; RISK; ADULT; INHALATIONAL DRUG ADMINISTRATION; LUNG VOLUME; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TIME FACTOR;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; AGED; BRONCHODILATOR AGENTS; COHORT STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TIME FACTORS;

EID: 84951574308     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.995292     Document Type: Article

References (29)

1. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www.goldcopd.org/ (accessed 11 December, 2012).
2. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350 (26): 2645-2653.
3. Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009; 64 (11): 939-943.
4. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008; 63 (9): 831-838.
5. George J, Kong DC, Thoman R, et al. Factors associated with medication nonadherence in patients with COPD. Chest 2005; 128 (5): 3198-3204.
6. Baiardini I, Braido F, Bonini M, et al. Why do doctors and patients not follow guidelines? CurrOpin Allergy ClinImmunol 2009; 9 (3): 228-233.
7. Tashkin DP. Multiple dose regimens. Impact on compliance. Chest 1995; 107 (5 Suppl): 176S-182S.
8. Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008; 3 (3): 371-384.
9. van Boven JF, Tommelein E, Boussery K, et al. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Res 2014; 15: 66.
10. Cecere LM, Slatore CG, Uman JE, et al. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD 2012; 9 (3): 25-25-8.
11. Krigsman K, Moen J, Nilsson JL, et al. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther 2007; 32 (6): 603-611.
12. Ismaila A, Corriveau D, Vaillancourt J, et al. Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients. Curr Med Res Opin 2014; 30 (7): 1427-1436.
13. Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy ClinImmunol 2006; 118 (4): 899-904.
14. Mehuys E, Boussery K, Adriaens E, et al. COPD management in primary care: an observational, community pharmacy-based study. Ann Pharmacother 2010; 44 (2): 257-266.
15. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. EurRespir J Suppl 1993; 16: 5-40.
16. van der Lende R, Jansen-Koster EJ, Knijpstra S, et al. [Prevalence of cold in Vlagtwedde and Vlaardingen (computer diagnosis versus doctors diagnosis)]. Ned TijdschrGeneeskd 1975; 119 (50): 1988-1996.
17. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005; 11 (7): 449-457.
18. van Grunsven PM, van Schayck CP, van DM, et al. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma 2000; 37 (3): 225-234.
19. From: SPC tekstOxisTurbohaler 12, inhalation powder. Available from: https:// www.medicines.org.uk/emc/medicine/190. (accessed 21 October, 2014).
20. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. ClinTher 2001; 23 (8): 1296-1310.
21. Stichting Farmaceutische Kengetallen. Therapy adherence data on Astma/COPD patients in the Netherlands including regional differences. Available from: http://www.therapietrouwmonitor.nl (accessed 27 November, 2012).
22. Alagha K, Palot A, Sofalvi T, et al. Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases. TherAdv Chronic Dis 2014; 5 (2): 85-98.
23. Available from: https:// www.nhg.org/nhg-standaarden (accessed 24 March, 2014).
24. Available from: http://www.diliguide.nl/document/zoeken/?q=COPD&search[cats][t][]=21&search[year][opt]=in& (accessed 24 March, 2014).
25. Elkout H, Helms PJ, Simpson CR, et al. Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children. PLoS One 2012; 7 (6): e39130.
26. Turner J, Wright E, Mendella L, et al. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. Chest 1995; 108 (2): 394-400.
27. Simmons MS, Nides MA, Rand CS, et al. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 2000; 118 (2): 290-295.
28. Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci 2008; 30 (5): 509-514.
29. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37 (9): 846-857.